deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Common Forms of Bre...(heritedit has taken painstaking research...),Health

Date:10/8/2008

herited, it has taken painstaking research to find genetic variants predisposing to the disease's common forms. The mutations in the BRCA1 and BRCA2 genes conferring very high risk have a less than 0.5 percent frequency in the general population in the United States and Europe, accounting for only 1-3% of all breast cancers.

Identifying and enabling the detection of a substantial proportion of the genetic risk for the common forms of breast cancer is the goal of deCODE's gene discovery work in breast cancer and the deCODE BreastCancer(TM) test. Women who know they are at a higher than average risk of breast cancer can also make proactive lifestyle changes to lower their lifetime risk, according to ACS. These include staying physically active, maintaining a healthy weight, eating healthy foods, and limiting alcohol intake and smoking.

About deCODE

deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of diagnostics and drugs for common diseases. deCODE is a global leader in gene discovery -- our population approach and resources have enabled us to isolate key genes contributing to major public health challenges from cardiovascular disease to cancer, genes that are providing us with drug targets rooted in the basic biology of disease. Through its CLIA-registered laboratory, deCODE is offering a growing range of DNA-based tests for gauging risk and empowering prevention of common diseases, including deCODE T2(TM) for type 2 diabetes; deCODE AF(TM) for atrial fibrillation and stroke; deCODE MI(TM) for heart attack; deCODE ProCa(TM) for prostate cancer; deCODE Glaucoma(TM) for a major type of glaucoma; and deCODE BreastCancer(TM) for the common forms of breast cancer. deCODE is delivering on the promise of the new genetics.SM Visit us on the web at http://www.decode.com; on our diagnostics site at ht
'/>"/>

SOURCE deCODE Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7
Related medicine news :

1. Open Biosystems Launches Decode RNAi Viral Screening Pools for Low-Cost Genome-Scale RNAi Screens
2. deCODE genetics to Webcast Presentation at Piper Jaffray Annual Healthcare Conference
3. deCODE genetics to Webcast Presentation at Lazard Capital Markets Annual Healthcare Conference
4. Candice Lane MD Launches Hormone Health MD Plus: The First Doctor Bioidentical Hormone Blog
5. Quantros Launches Patient Safety Organization Manager to Streamline PSO Data Management and Submission to the Network of Patient Safety Databases
6. Albertsons LLC Launches $4.99 Prescription Discount Program Covering Over 500 Generic Drugs
7. Reflex Stock Launches Exciting New Editorial Image Collections to the Worldwide Publishing Industry
8. Bounty Launches New Survival Guide Website for Dads
9. PPTA Launches New Educational Website on Donating Plasma
10. Drumlin Security Launches Ground-breaking Low Cost PDF Publishing Service
11. USHEALTH Group Launches Marketing Program for Two Health Insurance Plans Targeting Latino Residents in Florida